Accès libre

Role of interlekin-35 as a biomarker in patients with newly diagnosed Hashimoto’s thyroiditis

À propos de cet article

Citez

Hakki Yilmaz
Department of Internal Medicine, Dr. A. Y. Ankara Oncology Training and Research Hospital, Ankara, Turkey
M. Cakmak
Department of Internal Medicine, Turgut Ozal University, School of Medicine, Ankara, Turkey
B. Ceydilek
Department of Endocrinology, Turgut Ozal University, School of Medicine, Ankara, Turkey
C. Demir
Department of Endocrinology, Dr. A. Y. Ankara Oncology Training and Research Hospital, Ankara, Turkey
A. Aktas
Department of Endocrinology, Dr. A. Y. Ankara Oncology Training and Research Hospital, Ankara, Turkey